Abstract
Benign focal liver lesions, including cysts, hemangiomas, and focal nodular hyperplasia, are common. Annually, many patients worldwide undergo imaging for the work-up of a suspected or known abnormality of the liver. Cross-sectional imaging modalities, such as US, CT, and MR imaging, are used in most centers to assess liver abnormalities. These modalities, often used in various combinations, have fundamental differences in data acquisition and hence differences in the type of physical characteristics of tissues they interrogate. Currently, there is no consensus concerning the optimal strategy for liver imaging. Imaging modalities are often used based on the requests of referring physicians and the availability of equipment and experience of the radiologists. Most centers use US, CT, and CT-guided biopsy; MR imaging is often used as a problem-solving modality. The main goals of imaging are to assess (1) the nature of the lesions, (2) the number and size of liver abnormalities, and (3) the location of abnormalities relative to the vessels. All these aspects influence clinical and surgical decision making. This chapter describes a number of aspects of liver imaging including the current status and recent development of ultrasound, CT, and MR imaging and the role of these imaging modalities in the assessment of benign hepatic abnormalities.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Karhunen PJ (1986) Benign hepatic tumours and tumour like conditions in men. J Clin Pathol 39(2):183–188
Ishak KG, Rabin L (1975) Benign tumors of the liver. Med Clin North Am 59(4):995–1013
Valette PJ, Pilleul F, Crombe-Ternamian A (2003) MDCT of benign liver tumors and metastases. Eur Radiol 13(Suppl 5):M31–M41
Harvey CJ, Albrecht T (2001) Ultrasound of focal liver lesions. Eur Radiol 11(9):1578–1593
McNaughton DA, Abu-Yousef MM (2011) Doppler US of the liver made simple. Radiographics 31(1):161–188. doi:10.1148/rg.311105093
Shapiro RS, Wagreich J, Parsons RB, Stancato-Pasik A, Yeh HC, Lao R (1998) Tissue harmonic imaging sonography: evaluation of image quality compared with conventional sonography. AJR Am J Roentgenol 171(5):1203–1206. doi:10.2214/ajr.171.5.9798848
Hann LE, Bach AM, Cramer LD, Siegel D, Yoo HH, Garcia R (1999) Hepatic sonography: comparison of tissue harmonic and standard sonography techniques. AJR Am J Roentgenol 173(1):201–206. doi:10.2214/ajr.173.1.10397127
Tchelepi H, Ralls PW (2004) Ultrasound of focal liver masses. Ultrasound Q 20(4):155–169
Bolondi L, Correas JM, Lencioni R, Weskott HP, Piscaglia F (2007) New perspectives for the use of contrast-enhanced liver ultrasound in clinical practice. Dig Liver Dis 39(2):187–195. doi:10.1016/j.dld.2006.08.008
Sutherland T, Temple F, Lee WK, Hennessy O (2011) Evaluation of focal hepatic lesions with ultrasound contrast agents. J Clin Ultrasound 39(7):399–407. doi:10.1002/jcu.20847
Bartolotta TV, Taibbi A, Midiri M, Lagalla R (2009) Focal liver lesions: contrast-enhanced ultrasound. Abdom Imaging 34(2):193–209. doi:10.1007/s00261-008-9378-6
Quaia E, Calliada F, Bertolotto M, Rossi S, Garioni L, Rosa L et al (2004) Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 232(2):420–430. doi:10.1148/radiol.2322031401
Solbiati L, Tonolini M, Cova L, Goldberg SN (2001) The role of contrast-enhanced ultrasound in the detection of focal liver lesions. Eur Radiol 11(Suppl 3):E15–E26. doi:10.1007/s003300100003
Catala V, Nicolau C, Vilana R, Pages M, Bianchi L, Sanchez M et al (2007) Characterization of focal liver lesions: comparative study of contrast-enhanced ultrasound versus spiral computed tomography. Eur Radiol 17(4):1066–1073. doi:10.1007/s00330-006-0444-6
Li R, Guo Y, Hua X, He Y, Ding J, Guo A et al (2007) Characterization of focal liver lesions: comparison of pulse-inversion harmonic contrast-enhanced sonography with contrast-enhanced CT. J Clin Ultrasound 35(3):109–117. doi:10.1002/jcu.20310
Quaia E, D’Onofrio M, Palumbo A, Rossi S, Bruni S, Cova M (2006) Comparison of contrast-enhanced ultrasonography versus baseline ultrasound and contrast-enhanced computed tomography in metastatic disease of the liver: diagnostic performance and confidence. Eur Radiol 16(7):1599–1609. doi:10.1007/s00330-006-0192-7
Larsen LP, Rosenkilde M, Christensen H, Bang N, Bolvig L, Christiansen T et al (2007) The value of contrast enhanced ultrasonography in detection of liver metastases from colorectal cancer: a prospective double-blinded study. Eur J Radiol 62(2):302–307. doi:10.1016/j.ejrad.2006.11.033
Kopp AF, Heuschmid M, Claussen CD (2002) Multidetector helical CT of the liver for tumor detection and characterization. Eur Radiol 12(4):745–752. doi:10.1007/s00330-001-1177-1
Brancatelli G, Federle MP, Katyal S, Kapoor V (2002) Hemodynamic characterization of focal nodular hyperplasia using three-dimensional volume-rendered multidetector CT angiography. AJR Am J Roentgenol 179(1):81–85. doi:10.2214/ajr.179.1.1790081
Kamel IR, Georgiades C, Fishman EK (2003) Incremental value of advanced image processing of multislice computed tomography data in the evaluation of hypervascular liver lesions. J Comput Assist Tomogr 27(4):652–656
Kamel IR, Lawler LP, Fishman EK (2004) Comprehensive analysis of hypervascular liver lesions using 16-MDCT and advanced image processing. AJR Am J Roentgenol 183(2):443–452. doi:10.2214/ajr.183.2.1830443
Sahani D, Saini S, Pena C, Nichols S, Prasad SR, Hahn PF et al (2002) Using multidetector CT for preoperative vascular evaluation of liver neoplasms: technique and results. AJR Am J Roentgenol 179(1):53–59. doi:10.2214/ajr.179.1.1790053
Foley WD, Mallisee TA, Hohenwalter MD, Wilson CR, Quiroz FA, Taylor AJ (2000) Multiphase hepatic CT with a multirow detector CT scanner. AJR Am J Roentgenol 175(3):679–685. doi:10.2214/ajr.175.3.1750679
Paulson EK, McDermott VG, Keogan MT, DeLong DM, Frederick MG, Nelson RC (1998) Carcinoid metastases to the liver: role of triple-phase helical CT. Radiology 206(1):143–150. doi:10.1148/radiology.206.1.9423664
Frederick MG, Paulson EK, Nelson RC (1997) Helical CT for detecting focal liver lesions in patients with breast carcinoma: comparison of noncontrast phase, hepatic arterial phase, and portal venous phase. J Comput Assist Tomogr 21(2):229–235
Sheafor DH, Frederick MG, Paulson EK, Keogan MT, DeLong DM, Nelson RC (1999) Comparison of unenhanced, hepatic arterial-dominant, and portal venous-dominant phase helical CT for the detection of liver metastases in women with breast carcinoma. AJR Am J Roentgenol 172(4):961–968. doi:10.2214/ajr.172.4.10587129
Leifer DM, Middleton WD, Teefey SA, Menias CO, Leahy JR (2000) Follow-up of patients at low risk for hepatic malignancy with a characteristic hemangioma at US. Radiology 214(1):167–172. doi:10.1148/radiology.214.1.r00ja09167
Vilgrain V, Boulos L, Vullierme MP, Denys A, Terris B, Menu Y (2000) Imaging of atypical hemangiomas of the liver with pathologic correlation. Radiographics 20(2):379–397. doi:10.1148/radiographics.20.2.g00mc01379
Kim T, Federle MP, Baron RL, Peterson MS, Kawamori Y (2001) Discrimination of small hepatic hemangiomas from hypervascular malignant tumors smaller than 3 cm with three-phase helical CT. Radiology 219(3):699–706. doi:10.1148/radiology.219.3.r01jn45699
Semelka RC, Martin DR, Balci C, Lance T (2001) Focal liver lesions: comparison of dual-phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement. J Magn Reson Imaging 13(3):397–401
Miller FH, Hammond N, Siddiqi AJ, Shroff S, Khatri G, Wang Y et al (2010) Utility of diffusion-weighted MRI in distinguishing benign and malignant hepatic lesions. J Magn Reson Imaging 32(1):138–147. doi:10.1002/jmri.22235
Bhargava P, Vaidya S, Kolokythas O, Katz DS, Dighe M (2011) Hepatic vascular shunts: embryology and imaging appearances. Br J Radiol 84(1008):1142–1152. doi:10.1259/bjr/82649468
Semelka RC, Helmberger TK (2001) Contrast agents for MR imaging of the liver. Radiology 218(1):27–38. doi:10.1148/radiology.218.1.r01ja2427
Petersein J, Spinazzi A, Giovagnoni A, Soyer P, Terrier F, Lencioni R et al (2000) Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging–a multicenter phase III clinical study. Radiology 215(3):727–736. doi:10.1148/radiology.215.3.r00jn14727
Filippone A, Blakeborough A, Breuer J, Grazioli L, Gschwend S, Hammerstingl R et al (2010) Enhancement of liver parenchyma after injection of hepatocyte-specific MRI contrast media: a comparison of gadoxetic acid and gadobenate dimeglumine. J Magn Reson Imaging 31(2):356–364. doi:10.1002/jmri.22054
Goodwin MD, Dobson JE, Sirlin CB, Lim BG, Stella DL (2011) Diagnostic challenges and pitfalls in MR imaging with hepatocyte-specific contrast agents. Radiographics 31(6):1547–1568. doi:10.1148/rg.316115528
Klein D, Jenett M, Gassel HJ, Sandstede J, Hahn D (2004) Quantitative dynamic contrast-enhanced sonography of hepatic tumors. Eur Radiol 14(6):1082–1091. doi:10.1007/s00330-004-2299-z
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing AG Switzerland
About this chapter
Cite this chapter
De Cobelli, F., Ironi, G., Marra, P., Esposito, A., Del Maschio, A. (2015). Imaging Modalities. In: Aldrighetti, L., Cetta, F., Ferla, G. (eds) Benign Tumors of the Liver. Springer, Cham. https://doi.org/10.1007/978-3-319-12985-3_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-12985-3_5
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-12984-6
Online ISBN: 978-3-319-12985-3
eBook Packages: MedicineMedicine (R0)